March 2021- Volume 17, Issue 3

In this Issue

Editor's Focus

Cancer and clinical trials in the spotlight

Cancer and clinical trials in the spotlight

Cancer and clinical trials in the spotlight

March is still the month where we put extra attention on cancer, but the landscape is different in a pandemic
Out of order: Beyond exhausted

Out of order: Beyond exhausted

Out of order: Beyond exhausted

While there will no doubt be and end, the COVID pandemic is tiring all of us out right now

Commentary

Commentary: As COVID-19 research evolves, so too will animal models

Commentary: As COVID-19 research evolves, so too will animal models

Commentary: As COVID-19 research evolves, so too will animal models

Infectious disease researchers must expand the repertoire of animal models to advance their research

Special Reports

Feature

Focus Feature on Cancer

Focus Feature on Cancer

Focus Feature on Cancer

We explore advances in women’s cancers in addition to other recent oncology news

Discovery

Harnessing Electricity-Producing Bacteria

Harnessing Electricity-Producing Bacteria

Harnessing Electricity-Producing Bacteria

Potential exists for better detection and understanding of human disease
Blending datasets for better research

Blending datasets for better research

Blending datasets for better research

AI collaboration seeks to improve access to COVID-19 datasets across institutions

Single-cell sequencing vs. Schistosoma mansoni

Single-cell sequencing vs. Schistosoma mansoni

Single-cell sequencing vs. Schistosoma mansoni

Cell atlas of tropical disease parasite could highlight new targets for treatment
Autism answers within genetic disorders

Autism answers within genetic disorders

Autism answers within genetic disorders

Collaboration aims at drug discovery pipeline for monogenic causes of autism

Preclinical

Developing antibodies against SARS-CoV-2

Developing antibodies against SARS-CoV-2

Developing antibodies against SARS-CoV-2

DIOS-202 and DIOS-203 have been engineered for high potency and potential for avoiding escape mutants
Novel neuroprotection from Noveome

Novel neuroprotection from Noveome

Novel neuroprotection from Noveome

Data show full complement ST266 biologic offers better neuroprotection than fractionated formats
UC San Diego researchers target rare form of autism

UC San Diego researchers target rare form of autism

UC San Diego researchers target rare form of autism

Study could lead to future treatment for autism spectrum disorder that mostly affects girls

Clinical Trials

Antibody against Alzheimer’s

Antibody against Alzheimer’s

Antibody against Alzheimer’s

Lilly’s donanemab Phase 2 trial brings positive results
Roflumilast foam advances to Phase 3

Roflumilast foam advances to Phase 3

Roflumilast foam advances to Phase 3

Data show that roflumilast foam provides significant improvement for seborrheic dermatitis

Funding the jump to digital

Funding the jump to digital

Funding the jump to digital

Series C round to support Medable's plans for improving clinical trial technologies and options

Diagnostics

A different kind of TROLL

A different kind of TROLL

A different kind of TROLL

APIS and Moffitt pair up to assess TROLL lncRNAs as predictive biomarkers in cancer
Global effort on a neglected tropical disease

Global effort on a neglected tropical disease

Global effort on a neglected tropical disease

Health partners team up to speed up development of new schistosomiasis test
Bringing down the cost of cancer?

Bringing down the cost of cancer?

Bringing down the cost of cancer?

NuView’s theranostics approach could make cancer diagnosis and treatment more affordable
A first-in-class diagnostic for Parkinson’s disease

Tools & Technology

The three dimensions: Impact, metrics, and process
Bringing biologics into the wearable device world

Bringing biologics into the wearable device world

Bringing biologics into the wearable device world

Clinical trial data demonstrate potential for BD Libertas wearable drug delivery system 

Tools and services making the rounds

Tools and services making the rounds

Tools and services making the rounds

Find out about new offerings from BioTek, Repligen, Flow Eighteen38, and Cresset
Specifica sells antibody library platform to UCB

Specifica sells antibody library platform to UCB

Specifica sells antibody library platform to UCB

The Generation 3 Library Platform will boost UCB’s discovery efforts
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

May 2023 Front Cover

Latest Issue  

• Volume 19 • Issue 5 • May 2023

May 2023

May 2023 Issue